To the Editor,The State of Qatar is a small, oil-and gas-rich Gulf country that is experiencing rapid development in healthcare services, including pharmaceutical services. Stronger leadership based on a National Health Strategy and the development of pharmacy leadership groups at the practice level have contributed to the fast development of the practice of pharmacy in Qatar. Since 2006, the hospital pharmacy sector has developed a relatively new but rapidly evolving clinical pharmacy services that have been introduced in some of the nation's public hospitals.
1Current data suggest that a well-run, pharmacist-driven medication reconciliation (MR) process can reduce the occurrence of medication errors in hospitals, and the harm associated with these, consequently creating potential to improve patient safety and clinical outcomes.2 In 2013, hospital-based clinical pharmacists working at the newly established Al-Wakra Hospital initiated a MR process. Six months after the initiation of the program, a study was conducted to identify the types and frequency of medication discrepancies detected, and to document associated clinical pharmacy interventions made at the time of patients' admission to hospital. MR was conducted by all clinical pharmacists for inpatients across all wards (including the intensive care unit, medical and surgical wards) at the Al-Wakra Hospital for the period spanning March to October 2013. The study involved retrospective analysis of 251 MR forms. Data entry and data analysis were carried out using SPSS version 21.0. The Kolmogorov-Smirnov test was used to assess normality of data, and Spearman rho and Mann-Whitney U-tests were carried out to test for correlation and differences between variables.Of the 251 forms that were screened, 144 were found to have complete information. The percentage of instances of medication discrepancy was 39% (median number of discrepancies = 2), with the medication omission being the most common (median = 2). Cardiovascular medications (34%) followed by endocrine agents (22%) and nutrition/electrolyte supplements were the medicines most frequently associated with discrepancies. Clinical pharmacists changed/adjusted medications in approximately 25% of cases. The most common type of intervention was medication resumption. There was a significant correlation between the number of clinical interventions and percentage of discrepancies (Spearman rho coefficient = 0.479; p < 0.01). There was no significant difference between male and female patients in terms of percentage of medication discrepancies (p = 0.157) and rate of omission (p = 0.281).This study found that medication discrepancies at the time of hospital admission were very common in this new facility. The role of the MR form is invaluable in medication management functions conducted by the clinical pharmacists, and facilitated the resolution or prevention of medication discrepancies. Although more research in this area is required, we believe that the results of this study support the use of the MR form, and t...